Dror Ortho-Design, Inc. financial data

Symbol
DROR on OTC
Industry
Dental Equipment & Supplies
Location
480 Johnson Road, Suite 200, Washington, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
NOVINT TECHNOLOGIES INC (to 8/14/2023)
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276 % +6.51%
Debt-to-equity 60.9 % +29.9%
Return On Equity -570 % -153%
Return On Assets -354 % -90.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares +93.2%
Common Stock, Shares, Outstanding 957M shares +93.2%
Entity Public Float 4.31M USD 0%
Common Stock, Value, Issued 95.7K USD +93.2%
Weighted Average Number of Shares Outstanding, Basic 673M shares +127%
Weighted Average Number of Shares Outstanding, Diluted 673M shares +127%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.54M USD +44.8%
General and Administrative Expense 1.44M USD +35.5%
Operating Income (Loss) -5.22M USD -19.3%
Nonoperating Income (Expense) -9.87K USD -188%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.78M USD -61.9%
Net Income (Loss) Attributable to Parent -5.78M USD -61.9%
Earnings Per Share, Basic -0.01 USD/shares 0%
Earnings Per Share, Diluted -0.01 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.83M USD +6640%
Other Assets, Current 1.26K USD -77.1%
Assets, Current 639K USD -81.6%
Property, Plant and Equipment, Net 24.1K USD +937%
Assets 663K USD -80.9%
Accounts Payable, Current 215K USD +102%
Accrued Liabilities, Current 592 USD +0.34%
Liabilities, Current 907K USD +205%
Other Liabilities, Noncurrent 124K USD +2265%
Liabilities 1.03M USD +241%
Retained Earnings (Accumulated Deficit) -19.5M USD -42.1%
Stockholders' Equity Attributable to Parent -368K USD -112%
Liabilities and Equity 663K USD -80.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -781K USD +1.56%
Net Cash Provided by (Used in) Investing Activities -16.7K USD
Common Stock, Shares Authorized 3.25B shares +551%
Common Stock, Shares, Issued 957M shares +93.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -798K USD -0.56%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 549K USD -83.6%
Deferred Tax Assets, Valuation Allowance 11.3M USD +13.8%
Deferred Tax Assets, Gross 11.3M USD +13.8%
Depreciation 466 USD +179%
Payments to Acquire Property, Plant, and Equipment 16.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 9.88M USD +6.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 12.5M shares 0%
Unrecognized Tax Benefits 2.05M USD
Additional Paid in Capital 19M USD +13.1%
Preferred Stock, Shares Outstanding 5.85M shares -44.1%
Deferred Tax Assets, Net of Valuation Allowance 9.95M USD +374%
Share-based Payment Arrangement, Expense 2.25M USD -0.34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%